Amarin Corp Plc (AMRN)

[sstyles]

You are assuming that other generics are going to want to enter this quagmire. Teva has its own issues with GSK right now. They may think otherwise about getting into this battle. If that case stands, you think a judge or jury will take it lightly that Teva engaged in similar action with another pharma.

Dr. Reddy's may come to the same conclusion as well. Because of GSK v. Teva generic entry and sleeping well at night for the generics is no longer a given. Based on the Judge Newman's ruling in GSK v. Teva, one generic could be responsible for all the lost profits.

There is a lot of uncertainty here but that uncertainty could cost generics a lot of money. Then on top of that you have Amarin suing Hikma.